325 related articles for article (PubMed ID: 22144179)
1. GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α.
Flügel D; Görlach A; Kietzmann T
Blood; 2012 Feb; 119(5):1292-301. PubMed ID: 22144179
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia.
Cassavaugh JM; Hale SA; Wellman TL; Howe AK; Wong C; Lounsbury KM
J Cell Biochem; 2011 Dec; 112(12):3882-90. PubMed ID: 21964756
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of c-myc degradation by nickel compounds and hypoxia.
Li Q; Kluz T; Sun H; Costa M
PLoS One; 2009 Dec; 4(12):e8531. PubMed ID: 20046830
[TBL] [Abstract][Full Text] [Related]
4. The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs.
Liu N; Li H; Li S; Shen M; Xiao N; Chen Y; Wang Y; Wang W; Wang R; Wang Q; Sun J; Wang P
J Biol Chem; 2010 Jun; 285(24):18858-67. PubMed ID: 20388706
[TBL] [Abstract][Full Text] [Related]
5. Dual regulation of Fbw7 function and oncogenic transformation by Usp28.
Schülein-Völk C; Wolf E; Zhu J; Xu W; Taranets L; Hellmann A; Jänicke LA; Diefenbacher ME; Behrens A; Eilers M; Popov N
Cell Rep; 2014 Nov; 9(3):1099-109. PubMed ID: 25437563
[TBL] [Abstract][Full Text] [Related]
6. FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.
Wang R; Wang Y; Liu N; Ren C; Jiang C; Zhang K; Yu S; Chen Y; Tang H; Deng Q; Fu C; Wang Y; Li R; Liu M; Pan W; Wang P
Cell Res; 2013 Jun; 23(6):803-19. PubMed ID: 23507969
[TBL] [Abstract][Full Text] [Related]
7. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
8. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
Kannan MB; Dodard-Friedman I; Blank V
J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
[TBL] [Abstract][Full Text] [Related]
9. Usp28 counteracts Fbw7 in intestinal homeostasis and cancer.
Diefenbacher ME; Chakraborty A; Blake SM; Mitter R; Popov N; Eilers M; Behrens A
Cancer Res; 2015 Apr; 75(7):1181-6. PubMed ID: 25716680
[TBL] [Abstract][Full Text] [Related]
10. A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α).
Bialkowska AB; Liu Y; Nandan MO; Yang VW
J Biol Chem; 2014 Feb; 289(9):5997-6005. PubMed ID: 24398687
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
[TBL] [Abstract][Full Text] [Related]
12. Fbw7 and Usp28 regulate myc protein stability in response to DNA damage.
Popov N; Herold S; Llamazares M; Schülein C; Eilers M
Cell Cycle; 2007 Oct; 6(19):2327-31. PubMed ID: 17873522
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase 3 regulates expression of nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) and inhibits pro-survival function of Nrf1.
Biswas M; Kwong EK; Park E; Nagra P; Chan JY
Exp Cell Res; 2013 Aug; 319(13):1922-1931. PubMed ID: 23623971
[TBL] [Abstract][Full Text] [Related]
14. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic inactivation of glycogen synthase kinase-3β promotes gastric tumor growth and angiogenesis by facilitating hypoxia-inducible factor-1 signaling.
Ko YS; Cho SJ; Park J; Choi Y; Lee JS; Youn HD; Kim WH; Kim MA; Park JW; Lee BL
APMIS; 2016 Sep; 124(9):748-56. PubMed ID: 27365055
[TBL] [Abstract][Full Text] [Related]
16. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
[TBL] [Abstract][Full Text] [Related]
17. The FBW7-KLF2 axis regulates endothelial functions.
Zhao Y; Sun Y
Cell Res; 2013 Jun; 23(6):741-3. PubMed ID: 23567558
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner.
Flügel D; Görlach A; Michiels C; Kietzmann T
Mol Cell Biol; 2007 May; 27(9):3253-65. PubMed ID: 17325032
[TBL] [Abstract][Full Text] [Related]
19. Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.
Trausch-Azar JS; Abed M; Orian A; Schwartz AL
J Cell Physiol; 2015 Apr; 230(4):842-52. PubMed ID: 25204433
[TBL] [Abstract][Full Text] [Related]
20. Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells.
Chen MC; Chen CH; Chuang HC; Kulp SK; Teng CM; Chen CS
Hepatology; 2011 Jan; 53(1):148-59. PubMed ID: 21254166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
